Advanced Enzyme Technologies Salute del bilancio
Salute finanziaria criteri di controllo 6/6
Advanced Enzyme Technologies ha un patrimonio netto totale di ₹13.9B e un debito totale di ₹256.9M, che porta il suo rapporto debito/patrimonio netto a 1.8%. Le sue attività totali e le sue passività totali sono rispettivamente ₹15.5B e ₹1.6B. L'EBIT di Advanced Enzyme Technologies è ₹1.7B rendendo il suo rapporto di copertura degli interessi -16.8. Ha liquidità e investimenti a breve termine pari a ₹5.1B.
Informazioni chiave
1.8%
Rapporto debito/patrimonio netto
₹256.89m
Debito
| Indice di copertura degli interessi | -16.8x |
| Contanti | ₹5.07b |
| Patrimonio netto | ₹13.89b |
| Totale passività | ₹1.60b |
| Totale attività | ₹15.49b |
Aggiornamenti recenti sulla salute finanziaria
Nessun aggiornamento
Recent updates
After Leaping 26% Advanced Enzyme Technologies Limited (NSE:ADVENZYMES) Shares Are Not Flying Under The Radar
Aug 20
We Think Shareholders Are Less Likely To Approve A Pay Rise For Advanced Enzyme Technologies Limited's (NSE:ADVENZYMES) CEO For Now
Jul 19Advanced Enzyme Technologies (NSE:ADVENZYMES) Has Affirmed Its Dividend Of ₹1.00
Jul 13Advanced Enzyme Technologies' (NSE:ADVENZYMES) Returns On Capital Not Reflecting Well On The Business
Apr 08Advanced Enzyme Technologies (NSE:ADVENZYMES) Will Want To Turn Around Its Return Trends
Sep 23Advanced Enzyme Technologies (NSE:ADVENZYMES) Could Be Struggling To Allocate Capital
Feb 03Advanced Enzyme Technologies (NSE:ADVENZYMES) Will Want To Turn Around Its Return Trends
Aug 11With EPS Growth And More, Advanced Enzyme Technologies (NSE:ADVENZYMES) Is Interesting
May 13Returns On Capital At Advanced Enzyme Technologies (NSE:ADVENZYMES) Paint A Concerning Picture
Mar 28The Advanced Enzyme Technologies (NSE:ADVENZYMES) Share Price Has Gained 185%, So Why Not Pay It Some Attention?
Mar 13Don't Ignore The Fact That This Insider Just Sold Some Shares In Advanced Enzyme Technologies Limited (NSE:ADVENZYMES)
Feb 21Advanced Enzyme Technologies Limited's (NSE:ADVENZYMES) Stock's On An Uptrend: Are Strong Financials Guiding The Market?
Feb 18I Built A List Of Growing Companies And Advanced Enzyme Technologies (NSE:ADVENZYMES) Made The Cut
Feb 03
What Kind Of Investors Own Most Of Advanced Enzyme Technologies Limited (NSE:ADVENZYMES)?
Jan 19What Do The Returns On Capital At Advanced Enzyme Technologies (NSE:ADVENZYMES) Tell Us?
Dec 28The Advanced Enzyme Technologies (NSE:ADVENZYMES) Share Price Has Gained 114%, So Why Not Pay It Some Attention?
Dec 13Have Advanced Enzyme Technologies Limited (NSE:ADVENZYMES) Insiders Been Selling Their Stock?
Nov 28Are Strong Financial Prospects The Force That Is Driving The Momentum In Advanced Enzyme Technologies Limited's NSE:ADVENZYMES) Stock?
Nov 20Here's Why I Think Advanced Enzyme Technologies (NSE:ADVENZYMES) Might Deserve Your Attention Today
Nov 05What You Need To Know About Advanced Enzyme Technologies Limited's (NSE:ADVENZYMES) Investor Composition
Oct 21Analisi della posizione finanziaria
Passività a breve termine: Le attività a breve termine ( ₹8.1B ) di ADVENZYMES superano le sue passività a breve termine ( ₹1.0B ).
Passività a lungo termine: Le attività a breve termine di ADVENZYMES ( ₹8.1B ) superano le sue passività a lungo termine ( ₹564.4M ).
Storia e analisi del rapporto debito/patrimonio netto
Livello di debito: ADVENZYMES ha più liquidità del suo debito totale.
Riduzione del debito: Il rapporto debito/patrimonio netto di ADVENZYMES si è ridotto da 2.5% a 1.8% negli ultimi 5 anni.
Copertura del debito: Il debito di ADVENZYMES è ben coperto dal flusso di cassa operativo ( 553.6% ).
Copertura degli interessi: ADVENZYMES matura più interessi di quanti ne paga, quindi la copertura dei pagamenti degli interessi non è un problema.